Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London, WC1E 6BT, UK.
J Physiol. 2020 Aug;598(16):3417-3438. doi: 10.1113/JP279803. Epub 2020 Jun 18.
Loss-of-function mutations in proteins found at glycinergic synapses, most commonly in the α1 subunit of the glycine receptor (GlyR), cause the startle disease/hyperekplexia channelopathy in man. It was recently proposed that the receptors responsible are presynaptic homomeric GlyRs, rather than postsynaptic heteromeric GlyRs (which mediate glycinergic synaptic transmission), because heteromeric GlyRs are less affected by many startle mutations than homomers. We examined the α1 startle mutation S270T, at the extracellular end of the M2 transmembrane helix. Recombinant heteromeric GlyRs were less impaired than homomers by this mutation when we measured their response to equilibrium applications of glycine. However, currents elicited by synaptic-like millisecond applications of glycine to outside-out patches were much shorter (7- to 10-fold) in all mutant receptors, both homomeric and heteromeric. Thus, the synaptic function of heteromeric receptors is likely to be impaired by the mutation.
Human startle disease is caused by mutations in glycine receptor (GlyR) subunits or in other proteins associated with glycinergic synapses. Many startle mutations are known, but it is hard to correlate the degree of impairment at molecular level with the severity of symptoms in patients. It was recently proposed that the disease is caused by disruption in the function of presynaptic homomeric GlyRs (rather than postsynaptic heteromeric GlyRs), because homomeric GlyRs are more sensitive to loss-of-function mutations than heteromers. Our patch-clamp recordings from heterologously expressed GlyRs characterised in detail the functional consequences of the α1S270T startle mutation, which is located at the extracellular end of the pore lining M2 transmembrane segment (18'). This mutation profoundly decreased the maximum single-channel open probability of homomeric GlyRs (to 0.16; cf. 0.99 for wild type) but reduced only marginally that of heteromeric GlyRs (0.96; cf. 0.99 for wild type). However, both heteromeric and homomeric mutant GlyRs became less sensitive to the neurotransmitter glycine. Responses evoked by brief, quasi-synaptic pulses of glycine onto outside-out patches were impaired in mutant receptors, as deactivation was approximately 10- and 7-fold faster for homomeric and heteromeric GlyRs, respectively. Our data suggest that the α1S270T mutation is likely to affect the opening step in GlyR activation. The faster decay of synaptic currents mediated by mutant heteromeric GlyRs is expected to reduce charge transfer at the synapse, despite the high equilibrium open probability of these mutant channels.
在甘氨酸能突触中发现的蛋白质的功能丧失突变,最常见于甘氨酸受体(GlyR)的α1 亚基,导致人类出现惊跳病/强肌阵挛通道病。最近有人提出,负责的受体是突触前同型 GlyR,而不是突触后异型 GlyR(介导甘氨酸能突触传递),因为异型 GlyR 受许多惊跳突变的影响小于同型 GlyR。我们研究了位于 M2 跨膜螺旋胞外末端的α1 惊跳突变 S270T。当我们测量甘氨酸平衡应用对其反应时,这种突变对重组异型 GlyR 的损伤小于同型 GlyR。然而,用突触样毫秒甘氨酸应用到外面向外斑片诱发的电流在所有突变受体中都短得多(7-至 10 倍),无论是同型还是异型。因此,异型受体的突触功能可能因突变而受损。
人类惊跳病是由甘氨酸受体(GlyR)亚基或与甘氨酸能突触相关的其他蛋白的突变引起的。已知有许多惊跳突变,但很难将分子水平上的损伤程度与患者症状的严重程度相关联。最近有人提出,该疾病是由突触前同型 GlyR 功能障碍引起的(而不是突触后异型 GlyR),因为同型 GlyR 比异型 GlyR 对功能丧失突变更敏感。我们从详细表征的异源表达 GlyR 进行的膜片钳记录,阐明了位于孔衬 M2 跨膜片段(18')胞外末端的α1S270T 惊跳突变的功能后果。该突变极大地降低了同型 GlyR 的最大单通道开放概率(为 0.16;与野生型的 0.99 相比),但仅略微降低了异型 GlyR 的最大单通道开放概率(为 0.96;与野生型的 0.99 相比)。然而,异型和同型突变 GlyR 对神经递质甘氨酸的敏感性均降低。在外面向外斑片上短暂、准突触甘氨酸脉冲诱发的反应在突变受体中受损,因为去激活对于同型和异型 GlyR 分别快约 10 倍和 7 倍。我们的数据表明,α1S270T 突变可能影响 GlyR 激活的开放步骤。尽管这些突变通道的平衡开放概率很高,但突变异型 GlyR 介导的突触电流的更快衰减预计会减少突触处的电荷传递。